Skip to content

AbCellera Biologics Inc. ABCL Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$43.17M+5.4%-$8.95M+73.9%-$57.12M-11.8%-$34.73M+6.0%-$45.62M-12.3%
$5.92M+34.2%$5.18M+147%$4.3M+13.2%$4.5M+32.4%$4.41M+39.7%
$12.01M-18.8%$12.9M-15.3%$13.9M-19.0%$14.21M-20.1%$14.79M-15.1%
-$33.52M-190%-$34.74M-334%-$52.59M-82.1%-$32.4M-8.1%-$11.55M+72.3%
$3.83M-64.0%$9.84M-37.0%$8.93M-51.8%$13.37M-33.5%$10.64M-55.9%
-$25.08M-416%$75.14M+110%$36.49M+887%-$31.81M-161%$7.94M-73.5%
$7.19M+20.5%$4.12M-0.7%$7.37M+134%$5.97M+111%
-$51.45M-1,849%-$9.28M+57.2%-$66.83M-370%$2.94M+130%
-$37.35M-68.3%-$44.59M-88.7%-$61.52M-29.8%-$45.77M+8.6%-$22.19M+66.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does AbCellera Biologics Inc. generate?
AbCellera Biologics Inc. (ABCL) generated -$153.3M in operating cash flow over the trailing twelve months.
What is AbCellera Biologics Inc.'s free cash flow?
After $36.0M of capital expenditures, AbCellera Biologics Inc.'s free cash flow was -$189.2M over the trailing twelve months, down 32.1% year over year.
Where does AbCellera Biologics Inc.'s cash flow data come from?
Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.